Horizon Diagnostics, a business unit of Horizon Discovery Group plc, is a leading provider of genetically defined, human genomic reference standards, including FFPE cell line sections and purified genomic DNA. HDx™ Reference Standards offer a sustainable source of reference material to laboratories, proficiency schemes and manufacturers, providing an unprecedented level of control.
Personal Genome Diagnostics (PGDx) advances the frontiers of cancer medicine through innovative genomic technologies for oncology researchers, drug developers, clinicians and patients. The expert team at PGDx draws on a deep understanding of cancer biology and extensive experience in cancer genomics and clinical oncology to pioneer genomic methods. These novel technologies precisely identify and characterize unique genomic alterations in tumors.
Sysmex Inostics, a subsidiary of Sysmex Corporation, is a leader in blood-based molecular diagnostics testing in oncology. Our highly sensitive OncoBEAM™ kits and tests offer a minimally-invasive alternative for the detection of cancer gene mutations, clinical trials testing and companion diagnostics development.
At Precision for Medicine, we help our pharmaceutical and life sciences clients innovate, develop, and commercialize next generation medical products. Backed by a diverse team ofexperts across the spectrum of the healthcare marketplace, we provide a comprehensive and integrated set of services that help accelerate research, enable market adoption, enhancepatient outcomes, and realize the full commercial potential of new therapies and products.
Randox Laboratories has a longstanding reputation as a world leading diagnostic manufacturer, with innovative, high quality solutions designed to make diagnostic testing faster, more accurate and more reliable. Built on this heritage, Randox Biosciences, part of Randox Laboratories, specialises in supplying academic centres, genetics laboratories and the global biopharmaceutical industry with products tailored to their specific needs; whether that is for research, molecular diagnostics or clinical trials.